Attending PhysicianSarah Cannon
Disclosure information not submitted.
Safety and efficacy of Y-90 embolization in hepatocellular carcinoma (HCC) patients who have undergone prior resection: analysis of the RESiN registry (NCT02685631).
Monday, March 25, 20243:00 PM – 3:09 PM MT
Route90 US IDE Pivotal Study Early Results in Radioembolization of Hepatocellular Carcinoma (HCC) with Imageable Y90 Microspheres